Coave Therapeutics

Developer of gene therapy for ocular and neurological disease

placeParis, Ile De France, France calendar_todayFounded 2014 groups34 employees language coavetx.com

Social engagement

Social engagement: 7.1K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include Seroba Life Sciences, Novo Holdings, Bpifrance.

Investor typeCountShare
Venture capital528%
Private equity633%
Bank & private debt16%
Other / undisclosed633%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

31 Jan 2025 · Directeur du développement analytique · Lyon

Based on job postings tracked across public sources.

Recent activity

20 May 2026
Event
ASGCT Annual Meeting 2026
11 May 2026
Event
ASGCT Annual Meeting 2026
28 Apr 2026
Event
ASGCT Annual Meeting
Coming soon